Gene: ARHGEF33
Official Full Name: Rho guanine nucleotide exchange factor 33provided by HGNC
Gene Summary: Predicted to enable guanyl-nucleotide exchange factor activity. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO19702 | ARHGEF33 Knockout cell line (HeLa) | Human | ARHGEF33 | 1:3~1:6 | Negative | Online Inquiry |
ARHGEF33 Gene Knockout Cell Lines are genetically engineered cell lines where the ARHGEF33 gene has been specifically disrupted, resulting in the loss of its function. These cell lines serve as a powerful tool for studying the role of ARHGEF33 in various biological processes, including cell signaling, cytoskeletal dynamics, and cell migration. By effectively silencing the gene, researchers can investigate the downstream effects on cellular pathways and phenotypes, thereby understanding the gene's contribution to health and disease.
The primary function of ARHGEF33 involves its role as a guanine nucleotide exchange factor (GEF) that activates Rho GTPases, critical molecules that regulate actin cytoskeleton organization and cellular movement. The knockout of ARHGEF33 provides an invaluable resource for researchers to explore diseases such as cancer, where aberrant cell migration and invasion are often determinants of malignancy. Furthermore, these cell lines can be utilized in high-throughput screening assays to identify potential pharmacological agents targeting pathways influenced by Rho GTPases.
The scientific importance of ARHGEF33 Gene Knockout Cell Lines extends into both basic and applied research. They can be pivotal in elucidating disease mechanisms and drug discovery, making them essential for biomedical research laboratories and pharmaceutical companies alike. Compared to other gene knockout systems, our product offers high specificity and reproducibility, underpinned by cutting-edge CRISPR-Cas9 technology, ensuring that any observed effects are directly attributable to the loss of ARHGEF33 function.
This product stands out for its ease of use, versatility across various cell types, and the ability to generate stable lines with consistent performance. Additionally, the ability to regenerate the knockout lines with minimal time and effort accelerates research timelines, ensuring that researchers can focus on their primary goals rather than on lengthy genomic manipulation.
With years of expertise in the field of genetic engineering and a commitment to advancing scientific understanding, our company is dedicated to providing high-quality biological products that empower researchers and clinicians to make breakthroughs in their fields. ARHGEF33 Gene Knockout Cell Lines represent not only a significant research tool but also a gateway to innovations in understanding cellular behavior and designing targeted therapies.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.